Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 2
2011 4
2012 1
2014 1
2016 3
2017 2
2018 2
2019 5
2020 4
2021 5
2022 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.
van Schaik IN, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Praus M, Mielke O, Durn BL, Cornblath DR, Merkies ISJ; PATH study group. van Schaik IN, et al. Lancet Neurol. 2018 Jan;17(1):35-46. doi: 10.1016/S1474-4422(17)30378-2. Epub 2017 Nov 6. Lancet Neurol. 2018. PMID: 29122523 Free article. Clinical Trial.
Students' guide to documentation in clinical trials.
Heck J, Rath AK, Wons K, Schumacher C, Kutschenko A, Noltemeyer N, Ulaganathan S, Voßiek LJ, Hijma H, van Smeden J, Schröder C, Stichtenoth DO, Wedemeyer H, Schindler C, Bosch JJ. Heck J, et al. Among authors: kutschenko a. Eur J Clin Pharmacol. 2022 Nov;78(11):1861-1862. doi: 10.1007/s00228-022-03394-z. Epub 2022 Sep 30. Eur J Clin Pharmacol. 2022. PMID: 36180797 Free PMC article. Review.
A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity.
Klinkardt U, Schunk M, Ervin J, Schindler C, Sugimoto D, Rankin B, Amann R, Monti M, Kutschenko A, Schumacher C, Huber K, Zeder A, Heikkila N, Didierlaurent AM, Schwarz SE, Derouazi M. Klinkardt U, et al. Among authors: kutschenko a. Hum Vaccin Immunother. 2024 Dec 31;20(1):2410574. doi: 10.1080/21645515.2024.2410574. Epub 2024 Oct 14. Hum Vaccin Immunother. 2024. PMID: 39397784 Free PMC article. Clinical Trial.
Reduced Expression of GABA A Receptor Alpha2 Subunit Is Associated With Disinhibition of DYT-THAP1 Dystonia Patient-Derived Striatal Medium Spiny Neurons.
Staege S, Kutschenko A, Baumann H, Glaß H, Henkel L, Gschwendtberger T, Kalmbach N, Klietz M, Hermann A, Lohmann K, Seibler P, Wegner F. Staege S, et al. Among authors: kutschenko a. Front Cell Dev Biol. 2021 May 21;9:650586. doi: 10.3389/fcell.2021.650586. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34095114 Free PMC article.
Botulinum neurotoxin serotype D - A potential treatment alternative for BoNT/A and B non-responding patients.
Kutschenko A, Weisemann J, Kollewe K, Fiedler T, Alvermann S, Böselt S, Escher C, Garde N, Gingele S, Kaehler SB, Karatschai R, Krüger THC, Sikorra S, Tacik P, Wegner F, Wollmann J, Bigalke H, Wohlfarth K, Rummel A. Kutschenko A, et al. Clin Neurophysiol. 2019 Jun;130(6):1066-1073. doi: 10.1016/j.clinph.2019.02.007. Epub 2019 Feb 28. Clin Neurophysiol. 2019. PMID: 30871800
27 results